Literature DB >> 1913066

Neuro-endocrine cells--a new prognostic parameter in prostate cancer.

R J Cohen1, G Glezerson, Z Haffejee.   

Abstract

Neuro-endocrine cells are a recognised component of prostatic ducts and acini. Half of all clinically manifest cancers show neuro-endocrine differentiation. Occult carcinomas have a lower incidence of such differentiation. Neuro-endocrine cells are of major prognostic importance and appear more reliable in predicting patients' survival than do conventional histological grading systems.

Entities:  

Mesh：

Year:  1991        PMID： 1913066     DOI： 10.1111/j.1464-410x.1991.tb15318.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN： 0007-1331


  28 in total

1.  Novel combination of docetaxel and thymoquinone induces synergistic cytotoxicity and apoptosis in DU-145 human prostate cancer cells by modulating PI3K-AKT pathway.

Authors:  A Dirican; H Atmaca; E Bozkurt; C Erten; B Karaca; R Uslu
Journal:  Clin Transl Oncol       Date:  2014-07-25       Impact factor: 3.405

2.  A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells.

Authors:  E M Garabedian; P A Humphrey; J I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

3.  [Relevance of the neuroendocrine differentiation in prostatic carcinoma].

Authors:  C G Sauer; L Trojan; R Grobholz
Journal:  Pathologe       Date:  2005-11       Impact factor: 1.011

4.  Cells in various benign and malignant conditions of the human prostate express different antigenic phenotypes.

Authors:  O I Turhan; N E Aydin; O Sariyüce; S Ozkan
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

5.  Prostate cancer and neuroendocrine differentiation.

Authors:  M O Tan; U Karaoğlan; B Celik; O Ataoğlu; H Biri; I Bozkirli
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370

6.  A neuroendocrine/small cell prostate carcinoma xenograft-LuCaP 49.

Authors:  Lawrence D True; Kent Buhler; Janna Quinn; Emily Williams; Peter S Nelson; Nigel Clegg; Jill A Macoska; Thomas Norwood; Alvin Liu; William Ellis; Paul Lange; Robert Vessella
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

Review 7.  Neuroendocrine peptides in the prostate.

Authors:  P J Gkonos; A Krongrad; B A Roos
Journal:  Urol Res       Date:  1995

8.  Isolation and identification of L-dopa decarboxylase as a protein that binds to and enhances transcriptional activity of the androgen receptor using the repressed transactivator yeast two-hybrid system.

Authors:  Latif A Wafa; Helen Cheng; Mira A Rao; Colleen C Nelson; Michael Cox; Martin Hirst; Ivan Sadowski; Paul S Rennie
Journal:  Biochem J       Date:  2003-10-15       Impact factor: 3.857

9.  Long-term assessment of prostate cancer progression free survival: evaluation of pathological parameters, nuclear shape and molecular biomarkers of pathogenesis.

Authors:  Robert W Veltri; Sumit Isharwal; M Craig Miller; Jonathan I Epstein; Leslie A Mangold; Elizabeth Humphreys; Alan W Partin
Journal:  Prostate       Date:  2008-12-01       Impact factor: 4.104

10.  Neuroendocrine differentiation in human prostatic tumor models.

Authors:  M A Noordzij; W M van Weerden; C M de Ridder; T H van der Kwast; F H Schröder; G J van Steenbrugge
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.